MFW
ATXS

Mosaic Family Wealth’s Astria Therapeutics ATXS Stock Holding History

Mosaic Family Wealth’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-36
Closed -$1K – 694
2018
Q4 		$1K Hold
36
– – ﹤0.01% 609
2018
Q3 		$1K Buy
+36
New +$1.62K ﹤0.01% 620

Other funds holding ATXS

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Mosaic Family Wealth's ATXS Position: Q1 2019 in Review

Mosaic Family Wealth sold out of Astria Therapeutics (ATXS) in Q1 2019, closing a stake of 36 shares — an estimated $1K sold.

Mosaic Family Wealth first reported a position in ATXS in Q3 2018 and held it in 2 quarters. The position peaked at $1K in Q4 2018. 28 funds tracked by Wall St. Rank hold ATXS as of Q1 2019.

  • Mosaic Family Wealth reported no remaining Astria Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Mosaic Family Wealth sold 36 Astria Therapeutics shares in Q1 2019, an estimated $1K.
  • Mosaic Family Wealth first reported a position in Astria Therapeutics in Q3 2018 and held it in 2 quarters.
  • Mosaic Family Wealth's Astria Therapeutics position peaked at $1K in Q4 2018.
  • 28 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2019.

Based on Mosaic Family Wealth's 13F filing for Q1 2019, filed 14 May 2019.